Inhouse product
Indications
Perkirol is indicated for the treatment of the
signs and symptoms of idiopathic Parkinson's disease. It is also indicated for
the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Pharmacology
Ropinirole is a non-ergoline dopamine agonist.
Ropinirole has the highest affinity at the D3 receptors, which are concentrated
in the limbic areas of the brain and may be responsible for some of the
neuropsychiatric effects. The exact mechanism of action of ropinirole as a
treatment for Parkinson’s disease is unknown, however, it is believed to be
related to its ability to selectively stimulate dopamine D2 receptors within
the caudate-putamen system in the brain. This system affects body movement.
Negligible affinity is seen for ropinirole at α2 adrenoreceptors in the
periphery and 5HT-1 receptor. Ropinirole has no affinity at the D1-like
receptors, benzodiazepine or GABA receptors. The precise mechanism of action of
ropinirole as a treatment for Restless Legs Syndrome is unknown, however, it is
believed to be related to its ability to stimulate dopamine receptors.
Dosage &
Administration
Dosing for Parkinson's
disease: The recommended
starting dose for Parkinson's disease is 0.25 mg three times daily. Based on
individual patient therapeutic response and tolerability, if necessary, the
dose should then be titrated with weekly increments as described below. Maximum
recommended total daily dose of 24 mg (8 mg three times daily).
Dosing for Restless
Legs Syndrome: The recommended
adult starting dose for RLS is 0.25 mg once daily 1 to 3 hours before bedtime.
After 2 days, if necessary, the dose can be increased to 0.5 mg once daily, and
to 1 mg once daily at the end of the first week of dosing, then as shown below
as needed to achieve efficacy. Titration should be based on individual patient
therapeutic response and tolerability, up to a maximum recommended dose of 4 mg
daily.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
Because Perkirol is a dopamine agonist, it is
possible that dopamine antagonists such as neuroleptics (phenothiazines,
butyrophenones, thioxanthenes) or metodopramide may reduce the efficacy of
Perkirol.
Contraindications
It is contraindicated in patients known to
have a hypersensitivity to Ropinirole.
Side Effects
The most common side effects of Perkirol
include fainting, drowsiness, hallucinations, dizziness, nausea or vomiting,
uncontrolled sudden movements, leg swelling, fatigue, confusion, headache,
upset stomach, abdominal pain or discomfort, increased sweating etc.
Pregnancy &
Lactation
Pregnancy category C. There is no adequate and
well-controlled studies in pregnant women. It should be used during pregnancy
only if the potential benefit outweighs the potential risk to the fetus.
Ropinirole inhibits prolactin secretion in human and could potentially inhibit
lactation.
Precautions &
Warnings
Patients treated with Perkirol have reported
falling asleep while engaged in activities of daily living. Dopamine agonists
in clinical trials and clinical experience appear to impair the systemic regulation
of blood pressure, with resulting orthostatic hypotension.
Therapeutic Class
Antiparkinson drugs
Storage Conditions
Protect from light and moisture, store below
25°C. Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet